$ETNB
89bio, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023061921 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.614M $7.930M $4.844M
YoY Change 20.9% 63.71% 4.8%
% of Gross Profit
Research & Development $33.59M $31.42M $22.20M
YoY Change 76.21% 41.54% -5.91%
% of Gross Profit
Depreciation & Amortization $16.00K $10.00K $16.00K
YoY Change 6.67% -37.5% -30.43%
% of Gross Profit
Operating Expenses $41.21M $39.35M $27.04M
YoY Change 62.47% 45.5% -4.15%
Operating Profit -$39.35M -$27.04M
YoY Change 45.5% -4.15%
Interest Expense $4.838M $959.0K $535.0K
YoY Change 79.25%
% of Operating Profit
Other Income/Expense, Net $5.579M $238.0K
YoY Change 2244.12% -303.42%
Pretax Income -$36.37M -$34.73M -$26.80M
YoY Change 47.92% 29.56% -5.39%
Income Tax $3.867M $0.00 $2.000K
% Of Pretax Income
Net Earnings -$40.24M -$34.73M -$26.81M
YoY Change 63.54% 29.55% -5.38%
Net Earnings / Revenue
Basic Earnings Per Share -$0.45 -$0.57
Diluted Earnings Per Share -$0.50 -$0.45 -$0.57
COMMON SHARES
Basic Shares Outstanding 75.64M 75.48M 39.07M
Diluted Shares Outstanding 76.34M 47.25M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $578.9M $448.3M $193.3M
YoY Change 207.65% 131.87% 22.89%
Cash & Equivalents $316.2M $251.9M $72.40M
Short-Term Investments $262.7M $196.4M $120.9M
Other Short-Term Assets $14.66M $11.20M $6.513M
YoY Change 85.15% 71.96% -32.88%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $593.5M $459.5M $199.9M
YoY Change 202.7% 129.93% 19.65%
LONG-TERM ASSETS
Property, Plant & Equipment $46.00K $58.00K $105.0K
YoY Change -50.0% -44.76% -28.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $396.0K $289.0K $218.0K
YoY Change 37.02% 32.57% -75.06%
Total Long-Term Assets $2.735M $585.0K $726.0K
YoY Change 267.61% -19.42% -28.82%
TOTAL ASSETS
Total Short-Term Assets $593.5M $459.5M $199.9M
Total Long-Term Assets $2.735M $585.0K $726.0K
Total Assets $596.3M $460.1M $200.6M
YoY Change 202.95% 129.39% 19.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.585M $10.90M $14.15M
YoY Change -31.33% -22.95% 12.97%
Accrued Expenses $20.53M $14.13M $13.44M
YoY Change 71.89% 5.18% 83.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $6.667M
YoY Change
Total Short-Term Liabilities $29.61M $25.21M $34.42M
YoY Change 20.3% -26.76% 73.46%
LONG-TERM LIABILITIES
Long-Term Debt $24.80M $24.64M $12.96M
YoY Change 25.92% 90.13% 799.24%
Other Long-Term Liabilities $3.740M $100.0K $624.0K
YoY Change 444.4% -83.97%
Total Long-Term Liabilities $28.54M $24.64M $12.96M
YoY Change 44.91% 90.13% 799.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.61M $25.21M $34.42M
Total Long-Term Liabilities $28.54M $24.64M $12.96M
Total Liabilities $59.96M $49.90M $48.01M
YoY Change 33.27% 3.95% 125.52%
SHAREHOLDERS EQUITY
Retained Earnings -$457.4M -$417.2M -$290.6M
YoY Change 45.09% 43.54% 55.48%
Common Stock $993.5M $828.0M $443.7M
YoY Change 112.56% 86.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $536.3M $410.2M $152.6M
YoY Change
Total Liabilities & Shareholders Equity $596.3M $460.1M $200.6M
YoY Change 202.95% 129.39% 19.35%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$40.24M -$34.73M -$26.81M
YoY Change 63.54% 29.55% -5.38%
Depreciation, Depletion And Amortization $16.00K $10.00K $16.00K
YoY Change 6.67% -37.5% -30.43%
Cash From Operating Activities -$34.29M -$30.36M -$14.81M
YoY Change 26.56% 104.93% 10.15%
INVESTING ACTIVITIES
Capital Expenditures $4.000K $0.00 $0.00
YoY Change 100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$63.64M $38.32M -$42.06M
YoY Change 475.45% -191.11% -342.06%
Cash From Investing Activities -$63.64M $38.32M -$42.06M
YoY Change 475.38% -191.11% -342.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 162.2M -1.480M 68.63M
YoY Change 671.84% -102.16% 95220.83%
NET CHANGE
Cash From Operating Activities -34.29M -30.36M -14.81M
Cash From Investing Activities -63.64M 38.32M -42.06M
Cash From Financing Activities 162.2M -1.480M 68.63M
Net Change In Cash 64.24M 6.480M 11.76M
YoY Change -474.64% -44.89% 195.35%
FREE CASH FLOW
Cash From Operating Activities -$34.29M -$30.36M -$14.81M
Capital Expenditures $4.000K $0.00 $0.00
Free Cash Flow -$34.30M -$30.36M -$14.81M
YoY Change 26.57% 104.93% 10.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001785173
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-06-30
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39122
dei Entity Registrant Name
EntityRegistrantName
89bio, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4946844
dei Entity Address Address Line1
EntityAddressAddressLine1
142 Sansome Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Second Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
432-9270
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ETNB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75638516
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
251926000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55255000
CY2023Q3 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
196378000
CY2022Q4 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
132905000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11222000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7920000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
459526000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
196080000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
238000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
363000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
289000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
289000
CY2023Q3 us-gaap Assets
Assets
460111000
CY2022Q4 us-gaap Assets
Assets
196824000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10903000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12502000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14133000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11944000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
176000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
168000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25212000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24614000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
186000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24637000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20192000
CY2023Q3 us-gaap Liabilities
Liabilities
49902000
CY2022Q4 us-gaap Liabilities
Liabilities
44992000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
75000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
51000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
827878000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
467374000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-547000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-350000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-417197000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-315243000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
410209000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
151832000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
460111000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
196824000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31417000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22197000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88638000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61732000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7928000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4844000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21360000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15155000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
39345000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
27041000
us-gaap Operating Expenses
OperatingExpenses
109998000
us-gaap Operating Expenses
OperatingExpenses
76887000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39345000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27041000
us-gaap Operating Income Loss
OperatingIncomeLoss
-109998000
us-gaap Operating Income Loss
OperatingIncomeLoss
-76887000
CY2023Q3 us-gaap Interest Expense
InterestExpense
959000
CY2022Q3 us-gaap Interest Expense
InterestExpense
535000
us-gaap Interest Expense
InterestExpense
3928000
us-gaap Interest Expense
InterestExpense
1377000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5579000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
773000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11972000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
843000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34725000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26803000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101954000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77421000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-34725000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26805000
us-gaap Net Income Loss
NetIncomeLoss
-101954000
us-gaap Net Income Loss
NetIncomeLoss
-77424000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
41000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-136000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-200000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-408000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
47000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-122000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-197000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-376000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34678000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26927000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102151000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77800000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.5
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.63
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76336050
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76336050
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47253527
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47253527
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67962848
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67962848
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29413421
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29413421
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
151832000
CY2023Q1 etnb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
8960000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
185000
CY2023Q1 etnb Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
-693000
CY2023Q1 etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
482000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3551000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28836000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
110000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
445830000
CY2023Q2 etnb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
6630000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
327000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
142000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4137000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38393000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-354000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
441986000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
117000
CY2023Q3 etnb Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
-1597000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4381000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-34725000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
47000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
410209000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
125957000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2512000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25565000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-192000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
102741000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
43000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-69000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2586000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-25054000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
80185000
CY2022Q3 etnb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
53000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
208000
CY2022Q3 etnb Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
-53000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2500000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26805000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-122000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
152575000
us-gaap Profit Loss
ProfitLoss
-101954000
us-gaap Profit Loss
ProfitLoss
-77424000
us-gaap Share Based Compensation
ShareBasedCompensation
12069000
us-gaap Share Based Compensation
ShareBasedCompensation
7598000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4297000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
183000
etnb Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
285000
etnb Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
365000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
410000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
227000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1208000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
125000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
135000
us-gaap Depreciation
Depreciation
34000
us-gaap Depreciation
Depreciation
50000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3238000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4756000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-72000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1599000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7308000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2189000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3243000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-125000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-141000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94893000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53994000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
157428000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
87260000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
216804000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
110137000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59376000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22882000
etnb Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
296817000
etnb Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
88239000
etnb Proceeds From Issuance Public Offering At The Market Offering
ProceedsFromIssuancePublicOfferingAtTheMarketOffering
37089000
etnb Proceeds From Issuance Public Offering At The Market Offering
ProceedsFromIssuancePublicOfferingAtTheMarketOffering
8370000
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
24363000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
15590000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
53000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
629000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
237000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
142000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2290000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
122000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
21400000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
350940000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96820000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
196671000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19944000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55255000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52457000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
251926000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72401000
us-gaap Interest Paid Net
InterestPaidNet
1913000
us-gaap Interest Paid Net
InterestPaidNet
706000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
139000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
187000
etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
482000
etnb Remeasurement Of Lease Liability And Right Of Use Asset In Connection With Lease Modification
RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification
338000
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
448300000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain prior period amounts in the Company’s condensed consolidated statements of operations and comprehensive loss have been reclassified to conform to the current period presentation. Specifically, interest expense is disclosed separately on the Company’s condensed consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates </span><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include but are not limited to accrued research and development expenses, the fair value of stock options and unrecognized tax benefits. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> change in unrecognized tax benefits during the three months ended September 30, 2023. Unrecognized tax benefits increased by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million during the nine months ended September 30, 2023. This change had no impact on the effective tax rate because of corresponding deductions from deferred tax assets.</span></p>
CY2023Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
6700000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
316468000
CY2023Q3 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
39513000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
355981000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
175243000
CY2022Q4 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
6202000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
181445000
CY2023Q3 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
9193000
CY2022Q4 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
5727000
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
611000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
646000
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1418000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1547000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11222000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7920000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2023Q3 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
8684000
CY2022Q4 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
6499000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3937000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4165000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1432000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1052000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
228000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14133000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11944000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10774000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13036000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1190000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000000
CY2023Q3 us-gaap Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
285000
CY2023Q3 etnb Debt Instrument Carrying Amount Including Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentCarryingAmountIncludingPeriodicPaymentTermsBalloonPaymentToBePaid
25285000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
648000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24637000
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14282486
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11212805
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.916
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.992
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.899
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.046
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.034
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4381000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12069000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7598000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16679956
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17621091

Files In Submission

Name View Source Status
0000950170-23-061921-index-headers.html Edgar Link pending
0000950170-23-061921-index.html Edgar Link pending
0000950170-23-061921.txt Edgar Link pending
0000950170-23-061921-xbrl.zip Edgar Link pending
etnb-20230930.htm Edgar Link pending
etnb-20230930.xsd Edgar Link pending
etnb-ex31_1.htm Edgar Link pending
etnb-ex31_2.htm Edgar Link pending
etnb-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
etnb-20230930_pre.xml Edgar Link unprocessable
etnb-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
etnb-20230930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
etnb-20230930_cal.xml Edgar Link unprocessable
etnb-20230930_def.xml Edgar Link unprocessable